LENZ Therapeutics, Inc. LENZ

Filed with the SEC on Oct 28, 2026. Reported event date Oct 28, 2026.

Items reported in this filing

Item 2.02 Results of Operations and Financial Condition
Item 2.05 Costs Associated with Exit or Disposal Activities
The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.
Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
Item 9.01 Financial Statements and Exhibits

Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing